Imvax Gets Positive Overall Survival Data From Phase IIb GBM Asset

 
• By Alaric DeArment
  
glioblastoma
Imvax announced positive topline Phase IIb data for IGV-001 in GBM • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D